Evidence map›Paper›PMID 35736682›Full record

ReviewPlants (Basel, Switzerland)2022

Fruit Development in Sweet Cherry.

Edoardo Vignati, Marzena Lipska, Jim M Dunwell, Mario Caccamo, Andrew J Simkin

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bioactive Potential of Sweet Cherry (Foods (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Feeding the world: impacts of elevated [COHorticulture research · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Edoardo VignatiNIAB, New Road, East Malling ME19 6BJ, UK.
Marzena LipskaNIAB, New Road, East Malling ME19 6BJ, UK.
Jim M DunwellSchool of Agriculture, Policy and Development, University of Reading, Whiteknights, Reading RG6 6EU, UK.ORCID 0000-0003-2147-665X
Mario CaccamoNIAB, Cambridge Crop Research, Lawrence Weaver Road, Cambridge CB3 0LE, UK.
Andrew J SimkinNIAB, New Road, East Malling ME19 6BJ, UK.ORCID 0000-0001-5056-1306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fruits are an important source of vitamins, minerals and nutrients in the human diet. They also contain several compounds of nutraceutical importance that have significant antioxidant and anti-inflammatory roles, which can protect the consumer from diseases, such as cancer, and cardiovascular disease as well as having roles in reducing the build-up of LDL-cholesterol in blood plasma and generally reduce the risks of disease and age-related decline in health. Cherries contain high concentrations of bioactive compounds and minerals, including calcium, phosphorous, potassium and magnesium, and it is, therefore, unsurprising that cherry consumption has a positive impact on health. This review highlights the development of sweet cherry fruit, the health benefits of cherry consumption, and the options for increasing consumer acceptance and consumption.

Indexed as

fruit ripeningPrunus aviumrootstocktree fruit

Identifiers

PMID35736682
PMCPMC9227597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.